Return On Equity of POINT Biopharma Global Inc. from 31 Dec 2020 to 30 Sep 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
POINT Biopharma Global Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2020 to 30 Sep 2023.
  • POINT Biopharma Global Inc. Return On Equity for the quarter ending 30 Sep 2023 was 21%.
  • POINT Biopharma Global Inc. annual Return On Equity for 2022 was 31%.
  • POINT Biopharma Global Inc. annual Return On Equity for 2021 was -22%, a 83% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

POINT Biopharma Global Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2023 21% +52% 01 Jul 2023 30 Sep 2023
Q2 2023 23% +52% 01 Apr 2023 30 Jun 2023
Q1 2023 26% +48% 01 Jan 2023 31 Mar 2023
Q4 2022 31% +53% 01 Oct 2022 31 Dec 2022
Q3 2022 -31% -6.1% -24% 01 Jul 2022 30 Sep 2022
Q2 2022 -30% -2.8% -10% 01 Apr 2022 30 Jun 2022
Q1 2022 -22% +81% +79% 01 Jan 2022 31 Mar 2022
Q4 2021 -22% +104% +83% 01 Oct 2021 31 Dec 2021
Q3 2021 -25% 01 Jul 2021 30 Sep 2021
Q2 2021 -27% 01 Apr 2021 30 Jun 2021
Q1 2021 -102% 01 Jan 2021 31 Mar 2021
Q4 2020 -126% 01 Oct 2020 31 Dec 2020

POINT Biopharma Global Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2022 31% +53% 01 Jan 2022 31 Dec 2022
2021 -22% +104% +83% 01 Jan 2021 31 Dec 2021
2020 -126% 01 Jan 2020 31 Dec 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.